Skip to content

Drowning from the burden of drops? Rise above the flood Intervene early with iDose TR, an innovative procedural pharmaceutical1,2

Designed to deliver continuous intraocular pressure (IOP) control3

Helps reduce many of the burdens of
drops—compliance issues, possible disease progression, and administrative headaches3

Introduces your patients
to interventional glaucoma

8 of 10 patients were completely free of IOP-lowering drops at 12 months with iDose TR4

Are drops giving your patients the control they need?

iDose TR delivers continuous long-term prostaglandin analog therapy directly into the anterior chamber for IOP control with proven safety and patient tolerability.1,3,4

Discover Innovation

Ready to hear more?

Contact a representative to request more info.

Explore billing and coding resources

Learn more.

References: 1. iDose TR (travoprost intracameral implant) 75 mcg Prescribing Information. Glaukos Corporation. 2023. 2. Bacharach J, Blieden LS, Chaya C, et al. What does interventional glaucoma mean to you? Glaucoma Today. 2020:40-43. 3. Berdahl JP, Sarkisian SR Jr, Ang RE, et al. Efficacy and safety of the travoprost intraocular implant in reducing topical IOP‐lowering medication burden in patients with open‐angle glaucoma or ocular hypertension. Drugs. 2024;84(1):83-97. 4. Sarkisian SR, Ang RE, Lee AM, et al. Travoprost intracameral implant for open-angle glaucoma or ocular hypertension: 12-month results of a randomized, double-masked trial. Ophthalmol Ther. 2024;13(4):995-1014.

Important Safety Information

Dosage and Administration

For ophthalmic intracameral administration. The intracameral administration should be carried out under standard aseptic conditions.

Contraindications

iDose TR is contraindicated in patients with active or suspected ocular or periocular infections, patients with corneal endothelial cell dystrophy (e.g., Fuch’s Dystrophy, corneal guttatae), patients with prior corneal transplantation, or endothelial cell transplants (e.g., Descemet’s Stripping Automated Endothelial Keratoplasty [DSAEK]), patients with hypersensitivity to travoprost or to any other components of the product.

Warnings and Precautions

iDose TR should be used with caution in patients with narrow angles or other angle abnormalities. Monitor patients routinely to confirm the location of the iDose TR at the site of administration. Increased pigmentation of the iris can occur. Iris pigmentation is likely to be permanent.

Adverse Reactions

In controlled studies, the most common ocular adverse reactions reported in 2% to 6% of patients were increases in intraocular pressure, iritis, dry eye, visual field defects, eye pain, ocular hyperaemia, and reduced visual acuity.

Indications and Usage

iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Please see full Prescribing Information.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. You may also call Glaukos at 1-888-404-1644.

The information contained in this site is intended for US healthcare professionals only.

YES, I AM A US HEALTHCARE PROFESSIONAL NO, I AM NOT A US HEALTHCARE PROFESSIONAL

Request more info

"*" indicates required fields

*Required.

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.

Stay connected

Sign up to receive the latest information about iDose® TR!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
*Required.

Glaukos will use the information you provide on this form to get in touch with you.

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.